BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1235355)

  • 21. [Combination treatment of small cell bronchial carcinoma].
    Voss AC; Steinke B; Ostendorf P; Teller P; Gnann H
    Strahlentherapie; 1983 Jan; 159(1):18-21. PubMed ID: 6301108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Remission rates, survival, and prognostic factors in combination chemotherapy for bronchogenic carcinoma.
    Alberto P
    Cancer Chemother Rep 3; 1973 Mar; 4(2):199-206. PubMed ID: 4729321
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cytostatic therapy of tumors of the lung].
    De Marco F; Saviano G; Tenore G
    Arch Monaldi; 1974; 29(3-4):326-35. PubMed ID: 4463917
    [No Abstract]   [Full Text] [Related]  

  • 24. Small cell carcinoma of the lung: rapid development of acute leukemia.
    Jackson DV; Cruz JM; Woodruff R
    N C Med J; 1983 Aug; 44(8):475-6. PubMed ID: 6314156
    [No Abstract]   [Full Text] [Related]  

  • 25. High-dose cyclophosphamide versus cyclophosphamide, methotrexate, 5-FU, and hydroxyurea (CMFH) in the treatment of stage III non-small cell bronchogenic carcinoma: a randomized trial.
    Pannuti F; Lelli G; Casadio M; Piana E; Di Marco AR
    Cancer Treat Rep; 1980; 64(10-11):1131-4. PubMed ID: 7459899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chemotherapy of bronchopulmonary cancer. Trial of the BACON protocol].
    Adenis L; Restellini J; Caty A
    LARC Med; 1981 Nov; 1(2):50-1. PubMed ID: 6188012
    [No Abstract]   [Full Text] [Related]  

  • 27. Combination chemotherapy in inoperable lung cancer--a trial of 2 regimens.
    Behera D; Malik SK
    Indian J Chest Dis Allied Sci; 1989; 31(1):21-4. PubMed ID: 2509339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy of bronchogenic carcinomas by a combination of cyclophosphamide, methotrexate, vincristin and bleomycin.
    Schaerer R; Sotto JJ; Wiget U; Perdrix A; Bensa JC; Ribaud P
    Eur J Cancer (1965); 1977; 13(4-5):425-8. PubMed ID: 68881
    [No Abstract]   [Full Text] [Related]  

  • 29. Chemotherapy for small cell bronchogenic carcinoma: CCNU and doxorubicin compared to CCNU, doxorubicin, vincristine, and procarbazine.
    Vogelzang NJ; Trowbridge RC; Frenning DH; Theologides A; Kennedy BJ; Kelly DR; Ewing SL; Vosika GJ
    Cancer Treat Rep; 1980; 64(8-9):997-1000. PubMed ID: 6256076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cisplatin combination chemotherapy in non-oat cell carcinoma of the lung.
    Vincent RG; Lane WW; Raza S; Madajewicz S
    Cancer Treat Rep; 1982 Jan; 66(1):197-8. PubMed ID: 6975658
    [No Abstract]   [Full Text] [Related]  

  • 31. Combination chemotherapy and radiation therapy in small cell carcinoma of the lung.
    Eagan RT; Maurer LH; Forcier RJ; Tulloh M
    Cancer; 1973 Aug; 32(2):371-9. PubMed ID: 4722918
    [No Abstract]   [Full Text] [Related]  

  • 32. Acute ECG changes during cyclophosphamide infusion in a patient with bronchogenic carcinoma.
    Shachor J; Beker B; Geffen Y; Bruderman I
    Cancer Treat Rep; 1985 Jun; 69(6):734-5. PubMed ID: 4016782
    [No Abstract]   [Full Text] [Related]  

  • 33. Ifosfamide: a weekly dose fractionated schedule in bronchogenic carcinoma.
    Morgan LR; Posey LE; Rainey J; Bickers J; Ryan D; Vial R; Hull EW
    Cancer Treat Rep; 1981; 65(7-8):693-5. PubMed ID: 6265084
    [No Abstract]   [Full Text] [Related]  

  • 34. [MACC plus thymostimulin (TP-1 Serono) therapy of small cell bronchogenic carcinoma. Clinico-immunologic evaluation of the results of a randomized trial].
    Salvati F; Pallotta G; Antilli A; Nunziati F; De Marinis F; Lucchesi M
    G Ital Chemioter; 1984; 31(1-2):185-9. PubMed ID: 6088341
    [No Abstract]   [Full Text] [Related]  

  • 35. Small cell cancer of lung; rapid tumor necrosis leading to serious pulmonary infections after intensive chemotherapy.
    Brandman JR; Ruckdeschel JC; O'Donnell MR; Horton J
    N Y State J Med; 1981 Aug; 81(9):1332-4. PubMed ID: 6267528
    [No Abstract]   [Full Text] [Related]  

  • 36. Combination chemotherapy of bronchogenic carcinoma. I. Non-oat cell.
    Livingston RB
    Cancer Treat Rev; 1977 Sep; 4(3):153-65. PubMed ID: 73419
    [No Abstract]   [Full Text] [Related]  

  • 37. Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinoma.
    Evans WK; Feld R; DeBoer G; Osoba D; Curtis JE; Baker MA; Myers RE; Quirt IC; Pritchard KI; Brown TC; Kutas GJ; Blackstein ME; Ottema B; Millband L
    Cancer Treat Rep; 1981; 65(11-12):947-54. PubMed ID: 7028256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lessons from a time capsule: evolution, not revolution, in therapy for advanced non-small-cell lung cancer.
    Green MR
    J Clin Oncol; 2008 Jul; 26(19):3112-3. PubMed ID: 18591551
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of bronchopulmonary small cell carcinoma with a combination of cyclophosphamide and VP-16].
    González Larriba JL; Ordóñez Gallego A; Díaz Pérez MA; García de Paredes ML; Zamora P; Montero García JM
    Med Clin (Barc); 1984 May; 82(19):836-9. PubMed ID: 6330470
    [No Abstract]   [Full Text] [Related]  

  • 40. Combination chemotherapy for non-small cell bronchogenic carcinoma with bleomycin, doxorubicin, methotrexate, and cis-dichlorodiammineplatinum(II) (BAMP).
    Vogl SE; Wollner D; Kaplan BH; Berenzweig M
    Cancer Treat Rep; 1980; 64(4-5):717-9. PubMed ID: 6159081
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.